fbpx
12-10-2020

DeepIntent Patient Modeled Audiences Named One of the Most Innovative Products of 2020 by PM360

HIPAA-certified end-to-end advertising solution is the industry’s first to effectively reach specific patient populations in a privacy-safe way

NEW YORK, December 10, 2020 – DeepIntent, the leading healthcare marketing platform company purpose-built to influence positive health outcomes, today announced that its Patient Modeled Audiences solution has been named one of the Most Innovative Products of 2020 by PM360, a leading trade magazine for marketing decision-makers in the pharmaceutical, biotech, medical device, and diagnostics industries. 

“It’s an honor to have Patient Modeled Audiences awarded by PM360,” said Chris Paquette, founder and chief executive officer, DeepIntent. “Now more than ever as the public health crisis rages on, healthcare marketers need a way to reach patients with specific diagnoses in a quick and precise way without compromising accuracy or scale. Since its launch, Patient Modeled Audiences has provided the world’s leading pharmaceutical manufacturers unprecedented campaign performance that consistently outperforms the competition with 25% higher audience quality.”

Patient Modeled Audiences was selected as part of PM360’s 9th Annual Innovations Issue published each December. This issue was established to serve as a guide to the year’s most innovative Companies, Startups, Divisions, Products, Services, and Strategies from within the healthcare and life sciences industries. This comprehensive overview of the year’s most innovative achievements in these six categories helps other companies in the industry to find potential partners and offerings that can help them advance healthcare and life sciences.

“Innovation has been and will continue to be crucial as our industry and the world at large continues to deal with COVID-19 and the disruption and devastation it has caused,” says Anna Stashower, CEO, Publisher, and Editor-in-Chief of PM360. “The innovative companies, offerings, and strategies found in this year’s guide can provide the help that patients, healthcare professionals, or life sciences organizations need during this time as we all look toward making 2021 a healthier, safer, and overall better new year.” 

PM360 received hundreds of submissions from across the healthcare and life sciences industries. The editorial staff of PM360 evaluated each submission and selected their picks for the most innovative, regardless of category. Ultimately, 64 total innovations were featured in the issue. Within the Product category, a total of 16 products were featured.

In addition to this honor, DeepIntent’s healthcare DSP won Best Buy-Side Programmatic Platform against leading companies such as Xandr, Verizon Media, Cognitiv, Liftoff and Smadex in the 2020 Digiday Technology Awards. DeepIntent’s founder and CEO, Chris Paquette, also won PM360’s 2020 Trailblazer Vanguard Award.

All of this year’s selections can be found at: www.pm360online.com/pm360-presents-the-2020-innovators.  

About DeepIntent

Conceived by former Memorial Sloan Kettering data scientists, DeepIntent connects healthcare companies with patients and providers across every screen through unique data, premium media partnerships, and custom integrations. From campaign planning to audience targeting to measuring and optimizing towards outcomes, DeepIntent is proven to increase script lift while improving patients’ quality of life. DeepIntent’s Healthcare Marketing Platform enables over 20 major pharmaceutical companies and dozens of media agencies to advertise to more than 200 healthcare brands, so health and treatment decisions are made based on the latest, most pertinent information. For more information, visit deepintent.com. 

About PM360

PM360 is the premier, must-read magazine for marketing decision-makers in the pharmaceutical, biotech, medical device, and diagnostics industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment.

The journal’s targeted and insightful editorial focuses on issues that directly impact critical decision making, including: Planning and implementation of cutting-edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the “360” in the title signifies the span of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read.

By providing the full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.

Press Contact

Finn Partners for DeepIntent

Zander Wharton

deepintent@finnpartners.com

203-733-2815

More Insights

DeepIntent Expands Healthcare Marketplace By Integrating Major Supply Sources
5-18-2021

Partners with Magnite, Xandr, Pubmatic, and TripleLift; offers zero-fee trading for direct deals delivering higher yields and greater operational efficiency NEW YORK, May…

Read More
DeepIntent Launches DeepIntent Outcomes™
4-6-2021

Industry’s First Demand-Side Platform Integrated With Real-World Clinical Data to Increase Script Lift, Improving Business Outcomes for Healthcare Marketers Beta leading pharmaceutical brand experienced an…

Read More
DeepIntent Releases Consumer Survey Findings on Impact of Direct-to-Consumer Pharmaceutical Advertising
3-25-2021

Demonstrates gap between patients and providers about treatment options NEW YORK, March 25, 2021 – DeepIntent, the leading healthcare marketing technology company built purposefully to…

Read More
Subscribe to Our NewsletterJoin our mailing list to get the latest product updates, actionable insights, and resources for healthcare marketers and publishers.

By clicking ‘Submit’ you agree to our Terms and Privacy Policy